Essential fatty acids and mental illness
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in International Review of Psychiatry
- Vol. 18 (2) , 81-84
Abstract
The treatment of psychiatric illness requires novel pharmacological strategies. There is a growing body of evidence examining the role of neuronal phospholipid abnormalities in the pathogenesis of psychiatric illness, particularly in schizophrenia. However, work in other conditions like mood disorders are also showing interesting outcomes with EPA supplementation. Diseases that are considered to have a genetic basis may be significantly influenced by environmental factors including dietary supplementation. The suggestion that EFA supplementation may prevent the onset of symptoms of a psychiatric disease or aberrant behaviour needs longitudinal randomized controlled research. In recent years the focus has shifted from omega-6 to omega-3. It is true that western diets have far more omega-6 than omega-3. In the 1980s, there were positive outcomes in research studies using GLA in schizophrenia (Vaddadi et al., ). Future research needs to incorporate studies using pure GLA. Research should not be restricted to parent fatty acid (omega-3) supplementation alone but be expanded to include bioactive down-the-chain metabolites. The recent identification of novel omega-3 derived mediators such as resolvins and neuroprotectins, which are a highly bioactive (1–10 nMol range), may well have some role to play in psychiatric disorders; however this remains highly speculative at this stage.Keywords
This publication has 16 references indexed in Scilit:
- Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomised double-blind placebo-controlled studyThe British Journal of Psychiatry, 2006
- Effectiveness of Antipsychotic Drugs in Patients with Chronic SchizophreniaNew England Journal of Medicine, 2005
- Ethyl-EPA in Huntington diseaseNeurology, 2005
- Genetic and environmental factors in the pathogenesis of Huntington’s diseaseneurogenetics, 2004
- Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisonersThe British Journal of Psychiatry, 2002
- Synergistic Effects of Acetylcholine and Glutamate on the Release of Arachidonic Acid from Cultured Striatal NeuronsJournal of Neurochemistry, 1995
- The membrane hypothesis of schizophreniaSchizophrenia Research, 1994
- A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesiaPsychiatry Research, 1989
- Dietary control of diacylphosphatidylethanolamine species in brainBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Lipids of nervous tissue: Composition and metabolismProgress in Lipid Research, 1985